MELLOW Consortium welcomes the University of Cape Town as seventh member institution

The MELLOW Consortium has welcomed the University of Cape Town's Longevity Research Group as its seventh member institution, extending the network's trial footprint to the African continent for the first time.

Dr. Naledi Dlamini, who leads the group, will serve as lead investigator on the Consortium's skin and regenerative biology trial track.

"Longevity science has to be tested everywhere people actually live, not just in a handful of high-income countries," said Dlamini. "This partnership changes what our data can actually say."